Please enable JS

DISCOVER
OUR NEWS

News

Pfizer’s maternal RSV vaccine appears to win over FDA ahead of advisory meeting

May 22, 2023

Fierce Biotech The FDA seems to be satisfied that Pfizer’s RSV vaccine is safe and effective for administration in pregnant women to protect infants from severe disease. The agency’s confidence was revealed in briefing documents filed ahead of an advisory committee meeting set for Thursday. The Vaccines and Related Biological Products Advisory Committee will consider […]

READ MORE

News

WHO Announces End to COVID-19 Public Health Emergency of International Concern—At least Provisionally

May 22, 2023

Trial Site News The World Health Organisation (WHO) decided Thursday May 4, 2023, to end the COVID-19 public health emergency of international concern (PHEIC). TrialSite cautions that this is a provisional (temporary) status while WHO considers its forward-looking options (2023-2025). Importantly, in “The COVID-19 Emergency is Over, Sort of,” TrialSite reports that in America some […]

READ MORE

News

Participants first: Shaping the future of clinical trials through digital innovation

May 22, 2023

Mayo Clinic Clinical trials advance medicine, but the National Institutes of Health says that more than half of studies are unable to recruit or retain the necessary research participants, which can exacerbate health disparities. However, in recent years, digital technologies have helped trials become more accessible and inclusive. Clinical trials are moving out of traditional research facilities and […]

READ MORE

News

How to Rescue ‘Failed’ Clinical Trials and Minimize Risks

April 21, 2023

Applied Clinical Trials As with another oft-mentioned path, the road leading to regulatory approval is paved with good intentions. Clinical trials testing molecules once deemed to be of financial and medical value can, metaphorically at least, be found stacked up outside the regulator’s door. The many factors that halt a trial’s successful progress are a […]

READ MORE

Categories

News